itaconic acid has been researched along with rotenone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Adam-Vizi, V; Adams, D; Chinopoulos, C; Csépányi-Kömi, R; Csete, D; Doczi, J; Horvath, G; Iordanov, I; Kacso, G; Kiss, G; Mócsai, A; Nagy, AM; Németh, B; Ravasz, D; Tretter, L | 1 |
Albalakhi, A; Bakshi, R; Lin, S; Madore, V; Schwarzschild, MA; Stimpson, T; Xia, N; Xu, Y | 1 |
2 other study(ies) available for itaconic acid and rotenone
Article | Year |
---|---|
Abolition of mitochondrial substrate-level phosphorylation by itaconic acid produced by LPS-induced Irg1 expression in cells of murine macrophage lineage.
Topics: Animals; Cell Line; Chlorocebus aethiops; COS Cells; Female; Glycolysis; Hydro-Lyases; Lipopolysaccharides; Macrophages; Male; Malonates; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mitochondria, Liver; Mitochondrial ADP, ATP Translocases; Oxidative Phosphorylation; Rotenone; Succinate-CoA Ligases; Succinates | 2016 |
Microglia-dependent neuroprotective effects of 4-octyl itaconate against rotenone-and MPP+-induced neurotoxicity in Parkinson's disease.
Topics: Animals; Mice; Microglia; Neuroprotective Agents; Neurotoxicity Syndromes; NF-E2-Related Factor 2; Parkinson Disease; Rotenone | 2023 |